Search Results - "Liu, Yan-Rong"

Manipulating photodissociation dynamics via an embedding UV pulse.

Authors: Liu, Yan Rong Bai, Xin Nan, Quan Wei et al.

Source: Communications Physics. 8/14/2025, Vol. 8 Issue 1, p1-7. 7p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Prognostic significance of the frequencies of bone marrow lymphocyte subsets in adult acute myeloid leukemia at diagnosis.

Authors: Sun, Kai Wang, Jun Wang, Ya‐Zhe et al.

Source: International Journal of Laboratory Hematology. Apr2024, Vol. 46 Issue 2, p294-302. 9p.

Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations.

Authors: Deng, Dao-Xing Zhu, Hong-Hu Liu, Yan-Rong et al.

Source: Leukemia & Lymphoma. Sep2019, Vol. 60 Issue 9, p2181-2189. 9p.

Relationship between chronotypes and aggression in adolescents: a cross-sectional study.

Authors: Wang, Yuan Liu, Hao Wang, Yan-rong et al.

Source: BMC Psychiatry. 3/29/2023, Vol. 23 Issue 1, p1-8. 8p. 4 Charts, 1 Graph.

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.

Authors: Qin, Ya-Zhen Zhu, Hong-Hu Liu, Yan-Rong et al.

Source: Leukemia & Lymphoma. Jul2013, Vol. 54 Issue 7, p1442-1449. 8p.

Prevalence and risk factors of antibodies to HLA according to different cut‐off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjects.

Authors: Ma, Ning Guo, Jia‐Pei Zhao, Xiang‐Yu et al.

Source: HLA: Immune Response Genetics. Oct2022, Vol. 100 Issue 4, p312-324. 13p.

High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia.

Authors: Yang, Lu Chen, Wen‐Min Dao, Feng‐Ting et al.

Source: Cancer Medicine. Sep2019, Vol. 8 Issue 12, p5459-5467. 9p.

Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients.

Authors: Yang, Lu Dao, Feng-Ting Lu, Ai-Dong et al.

Source: Pediatric Hematology & Oncology. Mar2022, Vol. 39 Issue 2, p97-107. 11p.

Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia.

Authors: Wang, Jun Yang, Lu Dao, Feng-Ting et al.

Source: Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p152-161. 10p.

The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission.

Authors: Zhao, Xiao-Su Qin, Ya-Zhen Liu, Yan-Rong et al.

Source: Leukemia & Lymphoma. May2017, Vol. 58 Issue 5, p1135-1143. 9p.

High PRDM16 expression predicts poor outcomes in adult acute myeloid leukemia patients with intermediate cytogenetic risk: a comprehensive cohort study from a single Chinese center.

Authors: Dao, Feng-Ting Chen, Wen-Min Long, Ling-Yu et al.

Source: Leukemia & Lymphoma. Jan2021, Vol. 62 Issue 1, p185-193. 9p.

Osteoclast stimulatory transmembrane protein (OC‐STAMP) is a promising molecular prognostic indicator for multiple myeloma.

Authors: Wang, Zi‐Long Liu, Yang Zhou, Ya‐Lan et al.

Source: European Journal of Haematology. Aug2020, Vol. 105 Issue 2, p185-195. 11p.

Both Methylation and Copy Number Variation Participated in the Varied Expression of PRAME in Multiple Myeloma.

Authors: Yang, Lu Dao, Feng-Ting Chang, Yan et al.

Source: OncoTargets & Therapy. Jul2020, Vol. 13, p7545-7553. 9p.

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study.

Authors: Chang, Ying-Jun Wang, Yu Xu, Lan-Ping et al.

Source: Journal of Hematology & Oncology. 3/30/2020, Vol. 13 Issue 1, p1-13. 13p.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy.

Authors: Qin, Ya-Zhen Xu, Lan-Ping Chen, Huan et al.

Source: Leukemia & Lymphoma. Nov2015, Vol. 56 Issue 11, p3116-3123. 8p.

Using Ballistocardiogram and Impedance Plethysmogram for Minimal Contact Measurement of Blood Pressure Based on a Body Weight-Fat Scale.

Authors: Liu, Shing-Hong Wu, Yan-Rong Chen, Wenxi et al.

Source: Sensors (14248220). Feb2023, Vol. 23 Issue 4, p2318. 16p.

Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia.

Authors: Lu, Run-Qing Wu, Li-Xin Zhang, Jing et al.

Source: Hematology. Dec 2021, Vol. 26 Issue 1, p9-15. 7p.

Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinib.

Authors: Qin, Ya-Zhen Jiang, Qian Lai, Yue-Yun et al.

Source: Leukemia & Lymphoma. Jun2017, Vol. 58 Issue 6, p1384-1393. 10p.